A Randomised, Triple Blind, Placebo-Controlled Trial Comparing the Effects of Cognitive Therapy, Paroxetine and Both Cognitive Therapy and Paroxetine in the Treatment of Patients With Primary Social Phobia.
Phase of Trial: Phase IV
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Paroxetine (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- 04 Apr 2011 Status changed from active, no longer recruiting to completed, as reported in the ClinicalTrials.gov record
- 05 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Dec 2005 New trial record.